Livres : « AML acute myeloid leukaemia »

1

M, Carella Angelo, dir. Chronic myeloid leukaemia : Biology and treatment. London : Martin Dunitz, 2001.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

2

K, Burnett Alan, dir. Acute myeloid leukaemia. London : Baillière Tindall, 2001.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

3

Olwill, Shane. Annexin II expression in acute myeloid leukaemia. [S.l : The author], 2003.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

4

Barge, A. Acute myeloid leukaemia : The role of haematopoietic growth factors. Macclesfield : Gardner-Caldwell Communications, 1998.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

5

National Institute for Clinical Excellence. Guidance on the use of imatinib for chronic myeloid leukaemia. London : National Institute for Clinical Excellence, 2002.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

6

National Institute for Clinical Excellence. Guidance on the use of imatinib for chronic myeloid leukaemia. London : National Institute for Clinical Excellence, 2003.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

7

Hyde, K. The development of a CFU-GM Bioassay and its relationship to the French American British classification of acute Myeloid Leukaemia. Salford : University of Salford, 1991.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

8

Provan, Drew, Trevor Baglin, Inderjeet Dokal et Johannes de Vos. Leukaemia. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199683307.003.0004.

Texte intégral

Résumé :

Acute myeloblastic leukaemia (AML) - Acute lymphoblastic leukaemia (ALL) - Chronic myeloid leukaemia (CML) - Chronic lymphocytic leukaemia (B-CLL) - Prolymphocytic leukaemia (PLL) - Hairy cell leukaemia and variant - Large granular lymphocyte leukaemia (LGLL) - Adult T-cell leukaemia-lymphoma (ATLL)

Styles APA, Harvard, Vancouver, ISO, etc.

9

Provan, Drew, Trevor Baglin, Inderjeet Dokal, Johannes de Vos et Hassan Al-Sader. Leukaemia. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199683307.003.0004_update_001.

Texte intégral

Résumé :

Acute myeloblastic leukaemia (AML) - Acute lymphoblastic leukaemia (ALL) - Chronic myeloid leukaemia (CML) - Chronic lymphocytic leukaemia (B-CLL) - Prolymphocytic leukaemia (PLL) - Hairy cell leukaemia and variant - Large granular lymphocyte leukaemia (LGLL) - Adult T-cell leukaemia-lymphoma (ATLL)

Styles APA, Harvard, Vancouver, ISO, etc.

10

Goldman, John M., Angelo M. Carella, George Q. Daley, Connie J. Eaves et Hehlmann Rudiger. Chronic Myeloid Leukaemia : Biology and Treatment. Taylor & Francis Group, 2003.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

11

Ajithkumar, Thankamma, Ann Barrett, Helen Hatcher et Natalie Cook. Paediatric malignancies. Oxford University Press, 2011. http://dx.doi.org/10.1093/med/9780199235636.003.0015.

Texte intégral

Résumé :

Leukaemia is the commonest cancer (accounting for >40% of cases) in children. It is a clonal proliferation of stem cells which leads to bone marrow failure and tissue infiltration.• Acute lymphoblastic leukaemia (ALL): 4/100,000• Acute myeloid leukaemia (AML): 0.7/100,000• Chronic myeloid leukaemia (CML): 0.2/100,000...

Styles APA, Harvard, Vancouver, ISO, etc.

12

Cassidy, Jim, Donald Bissett, Roy A. J. Spence OBE, Miranda Payne et Gareth Morris-Stiff. Bone and soft tissue malignancies. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199689842.003.0025.

Texte intégral

Résumé :

Haematological malignancies examines the epidemiology, genetics, clinical presentation and classification of these diseases, and presents current treatment approaches for each. First are the acute leukaemias, and the management of acute lymphoblastic leukaemia (ALL) and acute myeloid leukaemia (AML). Chronic myeloid leukaemia, its genetics and sensitivity to tyrosine kinase inhibitors, is described. Myelodysplastic syndromes and their management, are followed by chronic lymphoid leukaemias, a large heterogeneous group of diseases, and their treatment. Hodgkin lymphoma, its pathology and presentation, staging and role of PET scanning, is described along with current treatment with chemotherapy and limited radiotherapy. Non-Hodgkin lymphoma is another heterogeneous group of diseases, divided into low-grade and high-grade pathology, and varying in their genetics, presentation, and management. Rituximab is a key component of chemotherapy regimens against B-cell lymphoma. Myeloma and other plasma cell dyscrasias are described, and treatment options reviewed. Myeloma remains incurable, but with appropriate management consistent with prolonged good quality life. Treatment includes chemotherapy, bisphosphonate therapy, analgesics and radiotherapy, Throughout this chapter is emphasised the importance of clinical trials in driving the rapid improvements in treatment of these diseases.

Styles APA, Harvard, Vancouver, ISO, etc.

13

Glasper, Edward Alan, Gillian McEwing et Jim Richardson, dir. Oncology. Oxford University Press, 2010. http://dx.doi.org/10.1093/med/9780198569572.003.0018.

Texte intégral

Résumé :

Related physiology 596The child with cancer 598Paediatric brain tumours 600Bone tumours 602Neuroblastoma 604Rhabdomyosarcoma (RMS) 606Acute myeloid leukaemia (AML) 608Acute lymphoblastic leukaemia (ALL) 610Wilms tumour 612T-cell acute lymphoblastic leukaemia 614Lymphoma 616Bone-marrow transplantation 618Related skills...

Styles APA, Harvard, Vancouver, ISO, etc.

14

McCann, Shaun R. Leukaemia. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780198717607.003.0007.

Texte intégral

Résumé :

The word leukaemia still is associated with foreboding and a fear of premature death. Steady advances have been made in the treatment of childhood leukaemia but, with notable exceptions, the same is not true in adults. The so-called genetic/molecular revolution has extended the understanding of the pathogenesis of many forms of leukaemia but, as yet, has rarely facilitated cure. With the introduction of tyrosine kinase inhibitor therapy, chronic myeloid leukaemia is the obvious exception but it still needs to be seen as to whether the cytogenetic/molecular revolution can provide cures for many elderly patients with leukaemia, as such patients respond poorly to chemotherapy. Haematopoietic stem cell transplantation, although toxic, expensive, and difficult, still provides a cure for many patients. In spite of all these advances, however, most adults with acute leukaemia or myelodysplastic syndrome are destined to die from their disease, and the causes of these fatal illnesses continue to elude researchers.

Styles APA, Harvard, Vancouver, ISO, etc.

15

Acute myeloid leukaemia. London : Baillière Tindall, 2001.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

16

Collins, Graham, et Chris Bunch. Acute leukaemia. Sous la direction de Patrick Davey et David Sprigings. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199568741.003.0286.

Texte intégral

Résumé :

Acute leukaemias are rapidly progressive, clonal haematopoietic stem cell disorders resulting in the accumulation of immature blood cell precursors (known as blasts) in the bone marrow. There are two main types, defined by the presence of myeloid lineage or lymphoid markers on the blast cells: acute myeloid leukaemia and acute lymphoblastic leukaemia. This chapter addresses the causes, diagnosis, and management of the acute leukaemias.

Styles APA, Harvard, Vancouver, ISO, etc.

17

Mendez, Irvin. Acute Myeloid Leukaemia : Symptoms, Diagnosis and Treatment. Nova Science Publishers, Incorporated, 2018.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

18

Bisoyi, Minati. Acute Myeloid Leukemia (AML) Signs, Symptoms, Causes, Prevent & Treatment. Independently Published, 2019.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

19

Linet, Martha S., Lindsay M. Morton, Susan S. Devesa et Graça M. Dores. Leukemias. Oxford University Press, 2017. http://dx.doi.org/10.1093/oso/9780190238667.003.0038.

Texte intégral

Résumé :

The 2001 World Health Organization (WHO) classification of hematopoietic and lymphoid neoplasms categorized “the leukemias” into two major groupings—myeloid and lymphoid. Myeloid neoplasms, which are the primary focus of this chapter, include acute myeloid leukemia (AML), myelodysplastic syndromes (MDS), and myeloproliferative neoplasms (MPN). Lymphoid neoplasms are mostly reviewed as part of non-Hodgkin lymphoma in Chapter 40 of this volume, although descriptive patterns and selected etiologic studies are briefly discussed in this chapter because of historical trends. Worldwide, leukemias are ranked eleventh among all cancer types, comprising approximately 2.5% of all malignancies. Exposure to ionizing radiation and certain chemical carcinogens (e.g., cytotoxic chemotherapy, benzene, formaldehyde) are the most consistently associated risk factors for MDS and/or AML. Radiation has been linked with CML, and cigarette smoking with AML. Fewer risk factors have been identified for MPNs. Some evidence implicates increased risks of AML in rubber workers, farmers, and other agricultural workers.

Styles APA, Harvard, Vancouver, ISO, etc.

20

Carton, James. Haematopathology. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780198759584.003.0015.

Texte intégral

Résumé :

This chapter discusses haematopathology, including iron deficiency anaemia, anaemia of chronic disease, megaloblastic anaemias, hereditary spherocytosis, glucose-6-phosphate dehydrogenase deficiency, thalassaemias, sickle-cell disorders, idiopathic thrombocytopenic purpura (ITP), thrombotic thrombocytopenic purpura (TTP), von Willebrand disease, haemophilia, thrombophilia, acute B-lymphoblastic leukaemia, acute myeloid leukaemias, chronic lymphocytic leukaemia (CLL), chronic myelogenous leukaemia, polycythaemia vera (PV), essential thrombocythaemia (ET), primary myelofibrosis (PMF), myelodysplastic syndromes (MDS), follicular lymphoma, diffuse large B-cell lymphoma, Burkitt’s lymphoma (BL), extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma), mantle cell lymphoma, classical Hodgkin’s lymphoma (cHL), lymphoplasmacytic lymphoma (LPL), plasma cell myeloma, primary amyloidosis, and mature T-cell non-Hodgkin’s lymphomas.

Styles APA, Harvard, Vancouver, ISO, etc.

21

McCann, Shaun R. Molecules, genes, and gene therapy. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780198717607.003.0009.

Texte intégral

Résumé :

The twenty-first century has brought many innovations in haematology, with improved diagnostic technology, which may inform treatment choices for malignant diseases, and a better understanding of the genetics and/or epigenetics underlying many diseases. Unfortunately, the aetiology of most of these diseases still eludes us, and some common diseases such as sickle cell disease await simple, inexpensive, and widely available curative treatment. For reasons that are often obscure, some diseases have become fashionable and attract large research financial backing, whereas some do not. With the advent of advanced technology and an improved understanding of disease mechanisms, most haematological malignancies should enjoy the same success as the treatment of childhood acute lymphoblastic leukaemia and chronic myeloid leukaemia.

Styles APA, Harvard, Vancouver, ISO, etc.

22

Provan, Drew, Trevor Baglin, Inderjeet Dokal et Johannes de Vos. Paediatric haematology. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199683307.003.0012.

Texte intégral

Résumé :

Blood counts in children - Red cell transfusion and blood component therapy—special considerations in neonates and children - Polycythaemia in newborn and childhood - Neonatal anaemia - Anaemia of prematurity - Haemolytic anaemia in the neonate - Congenital red cell defects - Acquired red cell defects - Haemolytic disease of the newborn - Hyperbilirubinaemia - Neonatal haemostasis - Neonatal alloimmune thrombocytopenia - Congenital dyserythropoietic anaemias - Congenital red cell aplasia - Acquired red cell aplasia - Fanconi anaemia - Rare congenital marrow failure syndromes - Neutropenia in childhood - Disorders of neutrophil function - Childhood immune (idiopathic) thrombocytopenic purpura - Haemolytic uraemic syndrome - Childhood cancer and malignant blood disorders - Childhood lymphoblastic leukaemia - Childhood lymphomas - Childhood acute myeloid leukaemia - Childhood myelodysplastic syndromes and chronic leukaemias - Histiocytic syndromes - Haematological effects of systemic disease in children

Styles APA, Harvard, Vancouver, ISO, etc.

23

Provan, Drew, Trevor Baglin, Inderjeet Dokal, Johannes de Vos et Angela Theodoulou. Paediatric haematology. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199683307.003.0012_update_001.

Texte intégral

Résumé :

Blood counts in children - Red cell transfusion and blood component therapy—special considerations in neonates and children - Polycythaemia in newborn and childhood - Neonatal anaemia - Anaemia of prematurity - Haemolytic anaemia in the neonate - Congenital red cell defects - Acquired red cell defects - Haemolytic disease of the newborn - Hyperbilirubinaemia - Neonatal haemostasis - Neonatal alloimmune thrombocytopenia - Congenital dyserythropoietic anaemias - Congenital red cell aplasia - Acquired red cell aplasia - Fanconi anaemia - Rare congenital marrow failure syndromes - Neutropenia in childhood - Disorders of neutrophil function - Childhood immune (idiopathic) thrombocytopenic purpura - Haemolytic uraemic syndrome - Childhood cancer and malignant blood disorders - Childhood lymphoblastic leukaemia - Childhood lymphomas - Childhood acute myeloid leukaemia - Childhood myelodysplastic syndromes and chronic leukaemias - Histiocytic syndromes - Haematological effects of systemic disease in children

Styles APA, Harvard, Vancouver, ISO, etc.

24

McCann, Shaun R. Combination chemotherapy. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780198717607.003.0012.

Texte intégral

Résumé :

One of the major advances in haematology during the past six decades has been the development of combination chemotherapy. However, some would dispute the claim that combination chemotherapy has been a major therapeutic advance, arguing that survival for most common cancers has not improved since the advent of chemotherapy. It is certainly true that the survival of children with acute lymphoblastic leukaemia has improved and that the drug imatinib mesylate and its derivatives have changed the outcome for most patients with chronic myeloid leukaemia. Likewise, combination chemotherapy has greatly modified the prognosis for patients with Hodgkin lymphoma and some types of non-Hodgkin lymphoma. However, it must be said that the application of combination chemotherapy to common non-haematological cancers has not met with similar success. In this chapter, the practicalities of the treatment of blood disorders are discussed, with specific reference to the use of this therapy by the medical profession.

Styles APA, Harvard, Vancouver, ISO, etc.

25

Lewis, Keir. Smoking. Sous la direction de Patrick Davey et David Sprigings. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199568741.003.0338.

Texte intégral

Résumé :

The UK government, in its White Paper in 1998, declared that ‘smoking is the greatest single cause of preventable illness and premature death in the UK’. Cigarette smoke is inhaled because it contains nicotine, which is highly addictive. Nicotine itself has some adverse physiological effects but it is mainly the 4000+ chemicals (including acetone, arsenic, paint stripper, pesticides, and over 60 known carcinogens), added to make the cigarette such an extremely potent nicotine delivery device, that cause so much damage.A smoker dies on average 8–10 years before a non-smoker does. The commonest causes of premature death in smokers are cardiovascular disease, lung cancer, and COPD. However, smoking also leads to much morbidity, causing or worsening many illnesses and affecting every system of the body. In addition, it is associated with a number of cancers, including lung cancer, nasopharyngeal cancer, laryngeal cancer, oesophageal cancer, stomach cancer, pancreatic cancer, colonic cancer, kidney cancer, bladder cancer, cervical cancer, and acute myeloid leukaemia. Stopping smoking at any age has been shown to improve health and increase life expectancy. Even with advanced smoking-related diseases, observational studies show clinically meaningful benefits in stopping smoking.

Styles APA, Harvard, Vancouver, ISO, etc.

Livres sur le sujet « AML acute myeloid leukaemia »

Créez une référence correcte selon les styles APA, MLA, Chicago, Harvard et plusieurs autres